RAPT 治疗技术公司通过销售830万股,每股30美元,筹集了2.5亿美元,承保人可以选择购买更多。 RAPT Therapeutics raised $250 million by selling 8.3 million shares at $30 each, with an option for underwriters to buy more.

RAPT 治疗公司以每股30美元的830万股价格公开出价830万股,在开销前筹集了约2.5亿美元,承保人可以选择再购买125万股。 RAPT Therapeutics priced a public offering of 8.3 million shares at $30 each, raising about $250 million before expenses, with underwriters holding an option to buy 1.25 million more shares. 由几家投资银行管理的这项提议将于2025年10月23日左右结束,但须符合标准条件。 The offering, managed by several investment banks, is set to close around October 23, 2025, subject to standard conditions. 股权是根据前证交会的货架登记而提供的。 Shares are being offered under a prior SEC shelf registration. 该公司警告说,实际结果可能因市场风险和监管风险而有所不同,正如其证交会档案中所概述的那样。 The company warns that actual results may differ due to market and regulatory risks, as outlined in its SEC filings.